Mysimba® can be collected from your local pharmacy with a prescription from your Doctor or Specialist.

For more information about Mysimba®, please visit the electronic compendium website at:
https://www.medicines.org.uk/emc/product/2684

Adverse events should be reported. Reporting forms and
information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Orexigen: +44 2039 660 116

.

For all other queries, please contact:

Email: [email protected]

Tel: +44 2039 660 116

Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Please consult your doctor or nurse for further information.

This website is intended for residents of the United Kingdom ages 18 and over only.

© 2018 Nalpropion Pharmaceuticals, Inc.

MYSIMBA® is a trademark of Nalpropion Pharmaceuticals, Inc., registered in the European Union.

MYS-0111-0001 08/2018

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close